Uncategorized

Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale – GlobeNewswire

Posted on Author Tim Hodges Comments Off on Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale – GlobeNewswire
  1. Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale  GlobeNewswire
  2. Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million  CNN
  3. Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million  WSJ
  4. 23andMe assets being sold to Regeneron Pharma for $256M  Axios
  5. 23andMe sells its most valuable asset. Regeneron promises keep your DNA private.  MarketWatch